Skip to main content

An update on the STRAVINSKY study: understanding who is most clinically vulnerable to COVID-19

BSI supported event
STRAVINSKY logo
Dates:
to
Location:
Online
Type:
Online
Register here

The ‘Stratification of Clinically Vulnerable People for COVID-19 Risk Using Antibody Testing’ (STRAVINSKY) study is pleased to hold a free public webinar on Thursday 31 October at 18:00-19:00 GMT to provide an update on the project’s progress so far as well as the current situation around COVID-19 for people with weakened immune systems as we head into winter. 

STRAVINSKY is a 2-year study, which aims to build our understanding of who is most clinically vulnerable to COVID-19 infection and identify individuals or disease groups at highest risk. Using this information, STRAVINSKY hopes to assess the effectiveness of COVID-19 booster vaccine programmes or new treatment strategies for these patients. 

Come along to this free webinar to hear from the study’s research team about STRAVINSKY’s progress and what the study has found to date, as well as the additional impacts that STRAVINSKY’s research is having. Recruitment for STRAVINSKY is due to close at the end of this year, so there is still time to take part.  If you’re still considering whether to sign up, please come along to find out more about the study and what’s involved.

This webinar is for a public audience with the opportunity for everyone to ask questions to our speaker. Questions can be submitted beforehand via the registration link below or you can ask them live at the event via the Q&A function. All questions submitted will be treated in an anonymous manner. Please note, we’re unable to answer questions about individual medical needs. 

Registration is free for all for this webinar and a recording will be available afterwards. Book your place here.  

Speakers 

  • Professor Alex Richter, STRAVINSKY lead researcher, University of Birmingham 

Chair

  • Hana Ayoob, British Society for Immunology